USANA Health Sciences, Inc. (NYSE: USNA) announced financial results for its fiscal fourth quarter and full-year ended December 29, 2018.
Fourth quarter 2018 net sales were $299.0 million, compared with $273.1 million in the prior-year period, or a 9.5 percent increase year-over-year. The company’s total number of active customers increased 9.0 percent year-over-year to 616,000.
“USANA finished the year with another quarter of solid results, bolstered by our annual China National Sales Meeting in Macau and a few targeted product promotions in select markets,” said Kevin Guest, chief executive officer.
Net sales in the Asia Pacific region increased by 12.2 percent to $243.3 million for the fourth quarter of 2018. The total number of active customers in the Asia Pacific region increased by 14.1 percent year-over-year. Net sales in the Americas and Europe region decreased by 1.1 percent to $55.8 million for the fourth quarter of 2018, primarily due to a 6.5 percent decrease in active customers.
Net sales for fiscal 2018 increased by 13.6 percent to $1.189 billion, compared with $1.047 billion in 2017. Changes in foreign currency exchange rates positively impacted net sales by $12.2 million. On a constant currency basis, net sales increased by 12.4 percent during fiscal 2018.
“Fiscal 2018 marks the 16th consecutive year that USANA has delivered record sales,” said Guest. “Outside of our financial performance, we accomplished several meaningful initiatives that generated momentum and better positioned us for continued growth into the future. Notably, Celavive® generated approximately $38 million in incremental sales in 2018, growing skincare sales to 9.0 percent of net sales in the fourth quarter.”
To view the full USANA Q4 2018 report, click here.
